Self correction for spatial orientation and motion of portable clinical analyzers

• US 9,904,761 B2
• Filed: 12/06/2013
• Issued: 02/27/2018
• Est. Priority Date: 12/17/2012
• Status: Active Grant

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Vandersleen, Gary, Emeric, Pierre, Wasserman, Paul, Soman, Narendra, Davis, Graham
• Primary Examiner(s): Marini, Matthew G
• Application Number:
  US14/099,479
• Publication Number:
  US 20140172341A1
• Time in Patent Office: 1,544 Days
• CPC Class Codes: G01N 27/3273 Devices therefor, e.g. test element readers, circuitry details not specific to biochemical electrodes G01N33/4875
• CPC Class Codes: G01N 27/3274 Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration coding of calibration information G01N33/48771
• CPC Class Codes: G01N 33/48785 Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
• CPC Class Codes: G16B 99/00 Subject matter not provided for in other groups of this subclass

Abstract

The present invention covers the integration and utility of accelerometer features into a clinical analysis system. For example, measurement of dynamic acceleration and orientation of a blood-testing instrument with respect to Earth'"'"'s gravitational field may be used to determine reliability of a test procedure and optionally to provide corrective elements thereof.

Claims

1. A portable clinical system for in vitro analysis of a sample comprising whole blood, the system comprising:

a test device comprising;

a sample entry port configured to receive the sample comprising the whole blood;

a conduit comprising at least one electrochemical sensor configured to generate an electric signal based on a concentration of a target analyte in the sample upon being contacted with the sample in the conduit; and

a pump configured to effect movement of the sample from the sample entry port through the conduit and over the at least one electrochemical sensor;

and

an analyzer comprising;

at least one accelerometer;

a port configured to receive the test device;

a computing device comprising one or more processors and non-transitory machine readable storage medium;

program instructions to determine spatial orientation and motion of the analyzer during a test cycle of the test device that includes the generating the electrical signal;

program instructions to compare the determined spatial orientation to a threshold operating spatial plane for the test device;

program instructions to compare the determined motion to a threshold rate of motion for the test device; and

program instructions to apply a correction factor to the electric signal generated by the at least one electrochemical sensor, when at least one of;

(i) the determined spatial orientation exceeds the threshold operating spatial plane, and/or (ii) the determined motion exceeds the threshold rate of motion, wherein the correction factor is at least one of a blood non-homogeneity correction factor, a blood cell sedimentation correction factor, and a blood motion factor, to produce a corrected signal,

wherein the program instructions are stored on the non-transitory machine readable storage medium for execution by the one or more processors.

2. The system of claim 1, wherein blood cells from the sample at least partially sediment on the at least one electrochemical sensor during the test cycle.

3. The system of claim 2, wherein a rate of cell sedimentation with respect to the at least one electrochemical sensor is dependent on at least one of the spatial orientation and the motion of the analyzer during the test cycle.

4. The system of claim 1, wherein the test device further comprises a calibration fluid for the at least one electrochemical sensor.

5. The system of claim 1, wherein the test device further comprises:

a wash fluid; and

a sensing reagent for the at least one electrochemical sensor.

6. The system of claim 1, wherein at least one electrochemical sensor responds to the target analyte or a property selected from the group consisting of:

hematocrit, troponin, creatine kinase myocardial band (CKMB), brain natriuretic peptide (BNP), beta human chorionic gonadotropin (bHCG), carbon dioxide partial pressure (pCO₂), partial pressure oxygen (pO₂), pH, prothrombin time (PT), activated clotting time (ACT), activated partial thromboplastin time (APTT), sodium, potassium, chloride, calcium, urea, glucose, creatinine, lactate, oxygen, and carbon dioxide.

7. The system of claim 1, wherein the analyzer further comprises program instructions to measure dynamic acceleration and static acceleration to determine the motion and the spatial orientation of the analyzer respectively.

8. The system of claim 1, wherein the computing device is configured to measure static acceleration on at least three axes of the analyzer to determine the spatial orientation of the analyzer, and the determining the spatial orientation comprises determining at least one of roll, pitch, and yaw of the analyzer based on the measured static acceleration on the at least three axes of the analyzer.

9. The system of claim 8, wherein:

the comparing the determined spatial orientation to the threshold operating spatial plane comprises at least one of;

comparing the determined roll of the analyzer to a threshold roll;

comparing the determined pitch of the analyzer to a threshold pitch; and

comparing the determined yaw of the analyzer to a threshold yaw; and

the applying the correction factor when the determined spatial orientation exceeds the threshold operating spatial plane comprises applying the correction factor when at least one of;

(i) the determined roll of the analyzer exceeds the threshold roll, (ii) the determined pitch of the analyzer exceeds the threshold pitch, and/or (iii) the determined yaw of the analyzer exceeds the threshold yaw.

10. The system of claim 1, wherein the analyzer further comprises:

program instructions to determine a stage of the test cycle;

program instructions to determine at least one of the threshold operating spatial plane and the threshold rate of motion based on the determined stage of the test cycle;

wherein at least one of;

the comparing the determined spatial orientation to the threshold operating spatial plane comprises comparing the determined spatial orientation to the determined threshold operating spatial plane for the determined stage of the test cycle; and

the comparing the determined motion to the threshold rate of motion comprises comparing the determined motion to the determined threshold rate of motion for the determined stage of the test cycle; and

at least one of;

the applying the correction factor when the determined spatial orientation exceeds the threshold operating spatial plane comprises applying the correction factor when the determined spatial orientation exceeds the determined threshold operating spatial plane for the determined stage of the test cycle; and

the applying the correction factor when the determined motion exceeds the threshold rate of motion comprises applying the correction factor when the determined motion exceeds the determined rate of motion for the determined stage of the test cycle.

11. The portable clinical system of claim 1, wherein the at least one electrochemical sensor responds to the target analyte or a property selected from the group consisting of:

hematocrit, troponin, creatine kinase myocardial band (CKMB), brain natriuretic peptide (BNP), activated clotting time (ACT), activated partial thromboplastin time (APTT), and prothrombin time international normalized ratio (PT INR).

12. The portable clinical system of claim 1, wherein the at least one electrochemical sensor responds to hematocrit.

13. The portable clinical system of claim 1, wherein the correction factor is at least one of a blood non-homogeneity correction factor or a blood cell sedimentation correction factor.

14. The system of claim 1, wherein the target analyte is troponin.

15. A method comprising:

inserting a test device for in vitro analysis of a sample comprising whole blood in a port of an analyzer,

wherein the test device comprises a sample entry port, a conduit comprising at least one electrochemical sensor configured to generate an electric signal based on a concentration of a target analyte in the sample upon being contacted with the sample in the conduit, and a pump configured to effect movement of the sample from the sample entry port through the conduit and over the at least one electrochemical sensor, and the analyzer comprises a computing device and at least one accelerometer;

initiating a test cycle of the test device that includes actuating the pump and moving the sample received by the test device over the at least one electrochemical sensor, and the at least one electrochemical sensor, upon being contacted with the sample in the conduit, generating the electric signal based on a concentration of a target analyte in the sample;

determining spatial orientation and motion of the analyzer during the test cycle of the test device by using the at least one accelerometer;

comparing the determined spatial orientation to a threshold operating spatial plane for the test device;

comparing the determined motion to a threshold rate of motion for the test device; and

applying a correction factor to the electric signal generated by the at least one electrochemical sensor, when at least one of;

(i) the determined spatial orientation exceeds the threshold operating spatial plane, and/or (ii) the determined motion exceeds the threshold rate of motion, wherein the correction factor is at least one of a blood non-homogeneity correction factor, a blood cell sedimentation correction factor, and a blood motion factor;

to produce a corrected signal.

16. A portable clinical system for in vitro analysis of a sample comprising whole blood, the system comprising:

a test device comprising;

a sample entry port configured to receive the sample comprising the whole blood;

a conduit comprising at least one immunosensor configured to generate an electric signal based on a concentration of a target analyte in the sample upon being contacted with the sample in the conduit; and

a pump configured to effect the movement of the sample from the sample entry port through the conduit and over the at least one electrochemical sensor;

and

an analyzer comprising;

at least one accelerometer;

a port configured to receive the test device; and

a computing device comprising one or more processors and non-transitory machine readable storage medium;

program instructions to determine spatial orientation and motion of the analyzer during a test cycle of the test device that includes the generating the electrical signal;

program instructions to compare the determined spatial orientation to a threshold operating spatial plane for the test device;

program instructions to compare the determined motion to a threshold rate of motion for the test device; and

program instructions to apply a correction factor to the electric signal generated by the at least one electrochemical sensor, when at least one of;

(i) the determined spatial orientation exceeds the threshold operating spatial plane, and/or (ii) the determined motion exceeds the threshold rate of motion, wherein the correction factor is at least one of a blood non-homogeneity correction factor, a blood cell sedimentation correction factor, and a blood motion factor, to produce a corrected signal,

wherein the program instructions are stored on the non-transitory machine readable storage medium for execution by the one or more processors.